Product Information
LOREEV XR 1 MG CAPSULE is a brand product labeled by Almatica Pharma LLC, priced at $14.2098 per EA under NDC 52427065830. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Aug 27, 2021.
The High Outlier badge above means this manufacturer's average price in the lorazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1 mg/1
Manufacturer
Almatica Pharma LLCNDC
52427065830
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORAZEPAMApproval Type
New Drug (NDA)
FDA Application
NDA214826FDA Approved
8/27/2021
On Market Since
8/31/2021
Pharmacological Classes
Price Statistics
The NADAC for LOREEV XR 1 MG CAPSULE has been published 129 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $14.2098 per EA |
|---|---|
| All-time high | $14.2841 (May 15, 2024) |
| All-time low | $14.2098 (Sep 23, 2026) |
| 52-week high | $14.2595 |
| 52-week low | $14.2098 |
| Median price | $14.2498 |
| Average price | $14.2493 |
| Largest weekly change | -0.2% (Jul 22, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lorazepam market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Almatica Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
lorazepam market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Benzodiazepine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LOREEV XR 1 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOREEV XR 1 MG CAPSULE, manufactured by Almatica Pharma LLC, is $14.2098 per EA (NDC 52427065830), effective Sep 30, 2026.
How has the price of LOREEV XR 1 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOREEV XR 1 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for LOREEV XR 1 MG CAPSULE?
Since Apr 17, 2024, the NADAC for LOREEV XR 1 MG CAPSULE has ranged from a low of $14.2098 (Sep 23, 2026) to a high of $14.2841 (May 15, 2024), with a median of $14.2498 per EA.
Are there cheaper alternatives to LOREEV XR 1 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of LOREEV XR 1 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LOREEV XR 1 MG CAPSULE?
LOREEV XR 1 MG CAPSULE (NDC 52427065830) is labeled by Almatica Pharma LLC, and CMS classifies it as a brand product.